Sampre Nutritions Posts Profit of ₹3.87 Crore in FY26, Reports Turnaround

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Sampre Nutritions Posts Profit of ₹3.87 Crore in FY26, Reports Turnaround
Overview

Sampre Nutritions Ltd has reported a significant turnaround, posting a standalone profit of ₹3.87 crore for FY26 against a loss in the previous year. The company also introduced consolidated results for the first time, reflecting a broader financial picture.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Sampre Nutritions Achieves Profitability in FY26

Sampre Nutritions Ltd has reported a standalone profit of ₹3.87 crore for the financial year ended March 31, 2026. This marks a significant turnaround from a loss of ₹7.31 crore in the previous fiscal year. The company's revenue from operations for FY26 stood at ₹43.35 crore, an increase from ₹25.12 crore in FY25.

What just happened

The company announced its audited financial results for the fiscal year 2026, showcasing a move from a net loss to a net profit on a standalone basis. For the fourth quarter ended March 31, 2026, Sampre Nutritions reported a profit of ₹1.82 crore on revenue from operations of ₹15.10 crore.

Why this matters

This financial recovery is crucial for investors as it signals a positive shift in the company's operational performance and profitability. The unmodified opinion from statutory auditors, N G Rao & Associates, adds credibility to these results.

The backstory

In the previous financial year, Sampre Nutritions faced a net loss of ₹7.31 crore. The current year's results demonstrate a strong recovery, with a profit of ₹3.87 crore.

What changes now

Sampre Nutritions has also begun presenting consolidated financial results for the first time, following its subscription to the capital of its wholly-owned subsidiary, Sampre Nutritions FZCO. The consolidated profit for FY26 was ₹3.08 crore on total revenue of ₹43.78 crore.

Risks to watch

While the turnaround is positive, investors should monitor the performance of the newly consolidated subsidiary and its contribution to the overall group profitability.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

Standalone revenue from operations grew from ₹25.12 crore in FY25 to ₹43.35 crore in FY26. Standalone profit turned around from a loss of ₹7.31 crore in FY25 to a profit of ₹3.87 crore in FY26.

What to track next

Investors should closely follow the performance of the consolidated entity, particularly the contribution of Sampre Nutritions FZCO, in upcoming financial reports.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.